Oncology

	Category	Product Name	ABC #	Size	NDC #	Manufacturer
	Oncology	Rubraca®	10245138	200 mg/60 tabs	69660-0201-91	Clovis Oncology
	Oncology	Rubraca®	10245518	250 mg/60 tabs	69660-0202-91	Clovis Oncology
	Oncology	Rybrevant™	10258682	350 mg/7 mL SDV	57894-0501-01	JOM product
	Oncology	Rylaze™	10259717	10 mg/3 × 0.5 mL SDV	68727-0900-03	Jazz Pharmaceuticals
	Oncology	Sarclisa®	10248254	500 mg/25 mL	00024-0656-01	Genzyme
	Oncology	Sarclisa®	10246453	100 mg/5 mL	00024-0654-01	Genzyme
	Oncology	Scemblix®	10262738	20 mg/60 tabs	00078-1091-20	Novartis
	Oncology	Scemblix®	10262737	40 mg/60 tabs	00078-1098-20	Novartis
	Oncology	Soliris®	10251107	300 mg/30 mL	25682-0001-01	Alexion Pharmaceutical
	Oncology	Somatuline® Depot	10244237	120 mg PFS	15054-1120-04	Ipsen Pharmaceuticals
	Oncology	Somatuline® Depot	10246715	60 mg PFS	15054-1060-04	Ipsen Pharmaceuticals
	Oncology	Somatuline® Depot	10247786	90 mg PFS	15054-1090-04	Ipsen Pharmaceuticals
	Oncology	Stivarga®	10244989	40 mg tabs	50419-0171-03	Bayer
	Oncology	Sustol®	10248815	10 mg/0.4 mL PFS kit 6/pk	47426-0101-06	Heron Therapeutics
	Oncology	Sutent®	10248919	12.5 mg/28 caps	00069-0550-38	Pfizer
	Oncology	Sutent®	10246849	50 mg/28 caps	00069-0980-38	Pfizer
	Oncology	Sutent®	10246459	25 mg/28 caps	00069-0770-38	Pfizer
	Oncology	Sutent®	10245663	37.5 mg/28 caps	00069-0830-38	Pfizer
	Oncology	Tafinlar®	10242019	50 mg/120 caps	00078-0682-66	Novartis
	Oncology	Tafinlar®	10243649	75 mg/120 caps	00078-0681-66	Novartis
	Oncology	Tagrisso®	10246862	80 mg/30 tabs	00310-1350-30	AstraZeneca
	Oncology	Tagrisso®	10244957	40 mg/30 tabs	00310-1349-30	AstraZeneca
	Oncology	Talzenna®	10247166	0.25 mg/30 caps	00069-0296-30	Pfizer
	Oncology	Talzenna®	10247257	1 mg/30 caps	00069-1195-30	Pfizer
	Oncology	Targretin®	10244412	1% gel 60 gm	00187-5525-60	Valeant Pharmaceuticals
	Oncology	Targretin®	10245413	75 mg SGC 100	00187-5526-75	Valeant Pharmaceuticals
	Oncology	Tasigna®	10241762	200 mg/28 caps	00078-0526-87	Novartis
	Oncology	Tasigna®	10243362	50 mg/120 caps	00078-0951-66	Novartis
	Oncology	Tasigna®	10238996	150 mg/28 caps	00078-0592-87	Novartis
	Oncology	Tazverik™	10248176	200 mg/240 tabs	72607-0100-00	Epizyme
	Oncology	Tecentriq®	10244254	840 mg/14 mL SDV	50242-0918-01	Genentech
	Oncology	Tecentriq®	10244387	1200 mg/20 mL SDV	50242-0917-01	Genentech
	Oncology	Tecvayli™	10274196	153 mg/1.7 mL SDV	57894-0450-01	Janssen Biotech
	Oncology	Tecvayli™	10274262	30 mg/3 mL SDV	57894-0449-01	Janssen Biotech
NEW	Oncology	Tepmetko®	10254462	225 mg/30 tabs DS	44087-5000-03	EMD Serono
	Oncology	Tibsovo®	10247140	250 mg/60 tabs	71334-0100-01	Agios Pharmaceuticals
	Oncology	Tivdak™	10261753	40 mg SDV	51144-0003-01	Seagen
	Oncology	Totect®	10250197	500 mg SDV	76310-0110-01	Clinigen
	Oncology	Trodelvy™	10245477	180 mg	55135-0132-01	Immunomedics .
Active	Oncology	Truqap™	10284653	200 MG TAB 64	00310-9501-01	Astrazenca
Active	Oncology	Truqap™	10284652	160 MG TAB 64	00310-9500-01	Astrazenca
	Oncology	Truseltiq™	10258944	100 mg/21 caps	72730-0111-01	QED Therapeutics
	Oncology	Truseltiq™	10258835	75 mg DAILY DOSE PK	72730-0202-01	QED Therapeutics
	Oncology	Truseltiq™	10258929	125 mg DAILY DOSE PK	72730-0101-01	QED Therapeutics
	Oncology	Truseltiq™	10258867	50 mg DAILY DOSE PK	72730-0506-01	QED Therapeutics
	Oncology	Tukysa™	10251131	150 mg/60 tabs	51144-0002-60	Seattle Genetics
	Oncology	Tukysa™	10251125	50 mg/60 tabs	51144-0001-60	Seattle Genetics
	Oncology	Tykerb®	10242580	250 mg/150 tabs	00078-0671-19	Novartis
	Oncology	Unituxin®	10241607	17.5 mg/5 mL SDV	66302-0014-01	United Therapeutics Corporation
	Oncology	Venclexta®	10248153	100 mg/180 tabs	00074-0576-34	Abbvie